The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 13, 2026
Filed:
Mar. 02, 2022
Applicant:
Dana-farber Cancer Institute, Inc., Boston, MA (US);
Inventors:
Nathanael S. Gray, Boston, MA (US);
Zhengnian Li, Boston, MA (US);
Jianwei Che, Sharon, MA (US);
Tinghu Zhang, Brookline, MA (US);
Assignee:
DANA-FARBER CANCER INSTITUTE, INC., Boston, MA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 498/18 (2006.01); A61K 31/4152 (2006.01); A61K 31/439 (2006.01); A61K 31/496 (2006.01); A61K 31/504 (2006.01); A61P 35/00 (2006.01); C07D 515/22 (2006.01);
U.S. Cl.
CPC ...
C07D 498/18 (2013.01); A61K 31/4152 (2013.01); A61K 31/439 (2013.01); A61K 31/496 (2013.01); A61K 31/504 (2013.01); A61P 35/00 (2018.01); C07D 515/22 (2013.01);
Abstract
The disclosure relates to compounds that act as covalent inhibitors of epidermal growth factor receptor (EGFR); pharmaceutical compositions comprising the compounds; and methods of treating or preventing kinase-mediated disorders, including cancer and other proliferation diseases.
Gray, Nathanael. (2026). Covalent egfr inhibitors and methods of use thereof (U.S. Patent No. 12760035). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12760035
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile